TKNO - Alpha Teknova, Inc.

6.49
-0.160   -2.465%

Share volume: 199,097
Last Updated: 04-25-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: 0.03%

PREVIOUS CLOSE
CHG
CHG%
$6.65
-0.16
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 0%
Dept financing 14%
Liquidity 67%
Performance 41%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.93%
1 Month
24.57%
3 Months
-31.97%
6 Months
-3.57%
1 Year
281.76%
2 Year
243.39%
Key data
Stock price
$6.49
P/E Ratio 
0.00
DAY RANGE
$6.31 - $6.57
EPS 
-$0.22
52 WEEK RANGE
$1.19 - $10.37
52 WEEK CHANGE
$281.76
MARKET CAP 
445.119 M
YIELD 
N/A
SHARES OUTSTANDING 
53.303 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
-0.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$339,705
AVERAGE 30 VOLUME 
$519,298
Company detail
CEO: Stephen Gunstream
Region: US
Website: teknova.com
Employees: 240
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion.

Recent news
loading